Adhera Therapeutics, Inc. (ATRX)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0099 (9,900.00%)
Aug 12, 2025, 8:00 PM EDT
Adhera Therapeutics Market Cap
Adhera Therapeutics has a market cap or net worth of $116.27 thousand as of August 13, 2025. Its market cap has decreased by -93.72% in one year.
Market Cap
116.27K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since November 16, 2016, Adhera Therapeutics's market cap has decreased from 2.98M to 116.27K, a decrease of -96.09%. That is a compound annual growth rate of -31.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.16K | -99.56% |
| Dec 29, 2023 | 261.60K | -89.91% |
| Dec 30, 2022 | 2.59M | 121.55% |
| Dec 31, 2021 | 1.17M | 153.66% |
| Dec 31, 2020 | 461.18K | -26.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |